Pacific Center for Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Pacific Center for Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7K	Hold	30	–	–	﹤0.01%	444
2025 Q4	$1.63K	Hold	30	–	–	﹤0.01%	422
2025 Q3	$1.63K	Hold	30	–	–	﹤0.01%	422
2025 Q2	$1.65K	Hold	30	–	–	﹤0.01%	406
2025 Q1	$2.12K	Hold	30	–	–	﹤0.01%	406
2024 Q4	$1.97K	Hold	30	–	–	﹤0.01%	411
2024 Q3	$2.11K	Hold	30	–	–	﹤0.01%	403
2024 Q2	$2.47K	Hold	30	–	–	﹤0.01%	395
2024 Q1	$2.62K	Hold	30	–	–	﹤0.01%	398
2023 Q4	$2.89K	Hold	30	–	–	﹤0.01%	334
2023 Q3	$2.65K	Hold	30	–	–	﹤0.01%	351
2023 Q2	$2.6K	Hold	30	–	–	﹤0.01%	342
2023 Q1	$2.92K	Buy	+30	New	+$3.11K	﹤0.01%	339

Other funds holding BMRN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return